# Sunz Fund

> Sunz Fund is a VC fund in Changsha backing Medical and Health Care. See 22 investments, round sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Changsha, China
- Total investments: 22
- Last investment: Mar 2026
- Lead investor: 41%
- Last updated: Aug 2026
- Website: http://www.sunzfund.com

Sunz Fund is a venture capital firm that focuses on investments in life science, medical health and resources environment sectors.

## Contacts

5 contacts available for Sunz Fund. Shizune tracks 1 team members at Sunz Fund. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/sunz-fund?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.4M–$7.4M |
| Series A | $1.4M–$14M |
| Series B | $2.8M–$2.8M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 10 | 45% |
| Health Care | 9 | 41% |
| Biotechnology | 9 | 41% |
| Biopharma | 3 | 14% |
| Manufacturing | 3 | 14% |

26 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 7 | 32% |
| Seed | 5 | 23% |
| Series B | 4 | 18% |
| Angel | 2 | 9% |
| Series C | 2 | 9% |

6 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Wen Zhou | Founder & President | 0 | https://shizune.co/investors/profile/wen-zhou |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Infineon Multiomics | Infineon Multiomics is a biotechnology company that provides research and application of space multiomics technology. | $7.4M | Seed | Mar 24, 2026 | http://www.infinityscopebio.com/ |
| Casibrain Technology | Casibrain Technology is a medical device enterprise that has grown up from the Institute of Automation. |  | Series B | Mar 10, 2026 | http://casibrain.com/ |
| Zhongnong Provenance | Zhongnong Provenance is an agricultural animal design and breeding service provider. |  | Series A | Nov 03, 2025 |  |
| Novomore Biotechnology | Hunan Nuohexin Biotechnology is a provider and developer of plant-derived recombinant protein expression products with technology research and product development, integrating production, research and development, sales, and services that can produce monoclonal antibodies, cell growth factors, vaccines, and plant-derived diagnostic antibodies. | $1.4M | Angel | Jul 03, 2024 | http://www.novomorebio.com/ |
| Zhihe Biotechnology | Zhihe Bio is a synthetic biology manufacturer of oleochemicals. | $1.4M | Seed | May 20, 2024 |  |
| Errui Xinyue | Errui Xinyue is a developer of early diagnosis technology and products for neurodegenerative diseases. It focuses on the research and use of exosome-related technologies and is committed to progressing the advancement of life and health through technological innovation. |  | Seed | Mar 12, 2024 |  |
| Changsha Morning Shine | Changsha Morning Shine is an innovative pharmaceutical company that specializes in R&D outsourcing, biomedicine, chemical drugs, and biotechnology services. | $14.1M | Series A | Dec 14, 2023 | https://www.csccyy.cn |
| Barty Medical | Barty Medical develops, manufactures, and markets coronary drug balloons, peripheral drug balloons, coronary PTCA balloons, peripheral PTA balloons, peripheral drug stents, supporting catheter sheaths, vascular interventional devices, and implanted devices. | $14.1M | Series C | Dec 14, 2023 | http://www.bartymedical.com |
| Maybio Matrix | Meibai bio focuses on the R&D, production & sales of biological scaffold material for maxillofacial tissue regeneration for medical and medical plastic and cosmetic clinical needs. |  | Series A | Sep 14, 2023 | https://www.maybio.cn/ |
| Yingsheng Biology | Yingsheng Biotechnology Co., Ltd. (referred to as Yingsheng Bio) was established in 2009, and is committed to the application of molecular diagnostic techniques such as maternal and child health, neonatal genetic diseases, metabolic diseases, birth defects and other human genetics, and national eugenics engineering. Yingsheng's product lineincludes 45 innovative genetic metabolic disease screening reagents, 14 vitamins determination reagents, mass spectrometer automatic intelligent processing platform, and ultra-high performance liquid chromatography tandem mass spectrometry detection system. level. |  | Series C | Mar 29, 2022 | http://www.ivdys.com/ |

10 of 22 investments shown.

## Co-investors
- [36Kr](https://shizune.co/investors/profile/36kr) — VC Fund, 1 deal together
- [Alibaba Group](https://shizune.co/investors/profile/alibaba) — VC Fund, 1 deal together
- [D.Z Capital](https://shizune.co/investors/profile/beijing-d-z-capital) — VC Fund, 1 deal together
- [BioVenture](https://shizune.co/investors/profile/bioventure) — VC Fund, 1 deal together
- [CD Capital](https://shizune.co/investors/profile/cd-capital) — VC Fund, 1 deal together
- [Changjin Holdings Industrial Capital](https://shizune.co/investors/profile/changjin-holdings-industrial-capital) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Medical Investors in China](https://shizune.co/investors/medical-investors-china)
- [Medical VC Funds in China](https://shizune.co/investors/medical-vc-funds-china)
- [Medical Investors in Asia](https://shizune.co/investors/medical-investors-asia)
- [Medical VC Funds in Asia](https://shizune.co/investors/medical-vc-funds-asia)
- [Life Science Investors in China](https://shizune.co/investors/life-science-investors-china)
- [Life Science VC Funds in China](https://shizune.co/investors/life-science-vc-funds-china)

## FAQ

### What does Sunz Fund invest in?

Sunz Fund invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A and Seed stage. Most of the 22 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What round sizes does Sunz Fund invest in?

Sunz Fund typically joins rounds of $1.4M–$7.4M at Seed, $1.4M–$14M at Series A and $2.8M–$2.8M at Series B. These are whole funding-round sizes, not Sunz Fund's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Sunz Fund took part in.

### How do I contact Sunz Fund?

Public channels for Sunz Fund include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Sunz Fund?

The team at Sunz Fund includes Wen Zhou (Founder & President). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co